CEL-SCI Corp (CVM)
0.59
-0.01
(-2.40%)
USD |
NYAM |
Nov 22, 09:40
CEL-SCI Enterprise Value: 36.79M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 36.79M |
| November 20, 2024 | 38.23M |
| November 19, 2024 | 39.29M |
| November 18, 2024 | 34.32M |
| November 15, 2024 | 34.06M |
| November 14, 2024 | 34.06M |
| November 13, 2024 | 38.36M |
| November 12, 2024 | 42.70M |
| November 11, 2024 | 43.89M |
| November 08, 2024 | 44.38M |
| November 07, 2024 | 42.64M |
| November 06, 2024 | 46.34M |
| November 05, 2024 | 48.81M |
| November 04, 2024 | 50.50M |
| November 01, 2024 | 53.30M |
| October 31, 2024 | 54.33M |
| October 30, 2024 | 54.83M |
| October 29, 2024 | 55.52M |
| October 28, 2024 | 56.19M |
| October 25, 2024 | 55.45M |
| October 24, 2024 | 55.25M |
| October 23, 2024 | 55.90M |
| October 22, 2024 | 56.46M |
| October 21, 2024 | 54.96M |
| October 18, 2024 | 54.96M |
| Date | Value |
|---|---|
| October 17, 2024 | 58.03M |
| October 16, 2024 | 60.20M |
| October 15, 2024 | 58.50M |
| October 14, 2024 | 60.80M |
| October 11, 2024 | 61.72M |
| October 10, 2024 | 61.72M |
| October 09, 2024 | 63.57M |
| October 08, 2024 | 64.18M |
| October 07, 2024 | 66.03M |
| October 04, 2024 | 66.03M |
| October 03, 2024 | 66.64M |
| October 02, 2024 | 67.87M |
| October 01, 2024 | 66.03M |
| September 30, 2024 | 64.80M |
| September 27, 2024 | 66.64M |
| September 26, 2024 | 64.18M |
| September 25, 2024 | 64.18M |
| September 24, 2024 | 65.41M |
| September 23, 2024 | 66.03M |
| September 20, 2024 | 66.03M |
| September 19, 2024 | 67.26M |
| September 18, 2024 | 68.49M |
| September 17, 2024 | 74.02M |
| September 16, 2024 | 70.33M |
| September 13, 2024 | 78.33M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
34.06M
Minimum
Nov 14 2024
1.105B
Maximum
Apr 27 2021
278.05M
Average
142.79M
Median
Aug 31 2022
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 9.017M |
| IGC Pharma Inc | 25.89M |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Protalix BioTherapeutics Inc | 94.82M |
| Palatin Technologies Inc | 15.96M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.857M |
| Total Expenses (Quarterly) | 6.670M |
| EPS Diluted (Quarterly) | -0.14 |
| Earnings Yield | -98.31% |